NCT07418385Recruiting
Voluntary HIV Screening in the General Population in France
Source: ClinicalTrials.gov · Last updated 18 Feb 2026
Brief summary (registry, in English)
Since 2020, an increase in positive screenings for sexually transmitted infections, including HIV, has been observed. Voluntary early screening plays an important role in the national strategy for HIV care in France. There are currently several methods that allow patients to undergo voluntary screening.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 11 Feb 2026
- Start date
- 7 Oct 2025
- Primary completion date
- 7 Apr 2026
- Lead sponsor
- Université de Reims Champagne-Ardenne
- Diseases
- HIV
- NCT number
- NCT07418385
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 7 Oct 2025 to the primary completion date, 7 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Minors
- Refusing to participate in the study
Who the study is looking for
- 18 years of age or older
- Male or female
- Regardless of sexual orientation
- Whether or not they have previously undergone voluntary HIV testing
- Agreeing to participate in the study.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ufr Medecine Urca Coordinator of this site? Confirm its status | Reims | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.